Impaired gut contractility following hemorrhagic shock is accompaied by IL-6 and G-CSF production and neutrophil infiltration.
Recovery from hemorrhagic shock (HS) is frequently accompanied by bowel stasis. The aim of this study was to examine whether or not HS initiates an inflammatory response that includes production of cytokines, specifically G-CSF and interleukin-6 (IL-6), and recruitment of leukocytes within the intestinal muscularis which contribute to impaired muscle contractility. Sprague-Dawley rats were subjected to HS (MAP 40 mm Hg for 156 min) followed by resuscitation, and then they were killed at 4 hr. Shock animals demonstrated accumulation of PMNs in the jejunal muscularis and decreased spontaneous and bethanechol-stimulated muscle contractility. Semiquantitative RT-PCR demonstrated elevated levels of IL-6 and G-CSF mRNA in shock animals in full-thickness jejunum and in mucosa and muscularis layers compared to sham controls. Immunostaining demonstrated increased IL-6 protein production within the muscularis externa and submucosa. In situ hybridization studies localized G-CSF mRNA production to the submucosa. Gel shift assays revealed increased NF-kappaB and Stat3 activity in full-thickness jejunum and jejunal layers of shock animals. Activation of Stat3 also was demonstrated in normal muscularis tissue exposed to IL-6 and G-CSF in vitro. IL-6 and G-CSF are produced in the muscularis and mucosa layers of the gut in HS where they may contribute to PMN recruitment and smooth muscle dysfunction.
Hierholzer
C
C
Department of Surgery, University of Pittsburgh School of Medicine, Pennsylvania 15213, USA.
Kalff
J C
JC
Chakraborty
A
A
Watkins
S C
SC
Billiar
T R
TR
Bauer
A J
AJ
Tweardy
D J
DJ
D000818:Animals; D004195:Disease Models, Animal; D005769:Gastrointestinal Motility / Q000276:immunology*; D016179:Granulocyte Colony-Stimulating Factor / Q000032:analysis / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D017403:In Situ Hybridization; D007249:Inflammation; D015850:Interleukin-6 / Q000032:analysis / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D007413:Intestinal Mucosa / Q000737:chemistry / Q000276:immunology; D007418:Intestinal Pseudo-Obstruction / Q000209:etiology* / Q000276:immunology* / Q000503:physiopathology; D007583:Jejunum / Q000737:chemistry / Q000276:immunology; D008297:Male; D009130:Muscle, Smooth; D018375:Neutrophil Activation / Q000276:immunology*; D012333:RNA, Messenger / Q000032:analysis; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012771:Shock, Hemorrhagic / Q000150:complications* / Q000276:immunology*
D015850:Interleukin-6; D012333:RNA, Messenger; D016179:Granulocyte Colony-Stimulating Factor